Cochlear Ltd. (ASX:COH) saw shares sag despite releasing fiscal year 2016 earnings today that showed annual net profit growing 30% while overall sales were up almost 25%. The Australian hearing aid giant reported profits of $144.9 million, or $2.54 per share, on sales of $888.6 million for the full 2016 fiscal year. That amounts to a […]
Earlens said today that it raised a funding round worth $51 million for the light-driven hearing aid it developed, pulling down $34 million in cash and another $17 million in a bridge financing conversion. The Earlens device, which last October won 510(k) clearance from the FDA, uses a laser diode attached to a behind-the-ear audio processor to […]
Cochlear Ltd. (ASX:COH) said today that the FDA cleared its Baha 5 SuperPower sound processor, which is designed to treat higher degrees of mixed hearing loss. The device allows users to stream audio directly from Apple devices including the iPhone, iPod Touch and iPad, via Bluetooth, the Centennial, Colo.-based company said. “The FDA clearance of the […]
(Reuters) – The Australian government said it is weighing a proposal from a consortium including hearing implant maker Cochlear Ltd. (ASX:COH) to buy a state-owned hearing service, a move likely to create headwinds from an electorate sensitive to privatised health. In a statement on Friday, Finance Minister Mathias Cormann said the government was approached by a […]
Steve Ubl, the longtime CEO at medical device lobby AdvaMed, is reportedly leaving the organization after 17 years to take the top spot at the pharmaceutical industry’s largest trade group, the Pharmaceutical Research and Manufacturers of America or PhRMA. The Hill, citing an unnamed source, said that Ubl “will more than likely” take over as […]
Zimmer (NYSE:ZMH), who acquired Biomet in a deal that closed this month, announced a series of personnel shifts upon the closure of the merger. Zimmer CFO and senior veep James Crines has stepped down from his position to retire, effective August 3, to be replaced by former CFO and senior veep of BiometDaniel Florin, the company said. […]
UPDATED March 21, 2013 with comments from Cochlear Americas president, principal investigator.